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Abstract Streptomyces lividans 1326-9, a bldA+ strain, and its
bldA39 mutant derivative J1725 were transformed with a cosmid
containing the pur cluster, which determines the puromycin
biosynthetic pathway from Streptomyces alboniger. bldA+
transformants produced puromycin in typical amounts, whereas
bldA39 transformants did so at drastically decreased levels.
Transformation of low producers with the wild-type bldA gene
reverted this phenotype to normal production. These data, in
addition to the presence of a TTA codon in the amino-terminal
coding region of the pur10 and pur6 genes of the pur cluster,
suggest that the puromycin biosynthetic pathway is translation-
ally dependent on the bldA gene product, a tRNALeu.
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1. Introduction
The bld mutants of Streptomyces coelicolor are de¢cient in
the formation of aerial mycelium despite their apparent nor-
mality in vegetative growth. In addition, most are blocked in
the synthesis of a variety of antibiotics [1^3]. This establishes
a link between the morphological and physiological di¡eren-
tiation of these organisms and is therefore the subject of stud-
ies to ¢nd the mechanisms regulating both processes. bldA
encodes the single tRNALeu which recognizes the UUA codon
[4,5]. This codon is extremely rare in Streptomyces mRNAs,
given the high content of G/C in their DNA (approximately
73%). The presence of TTA codons is almost restricted to
those genes which are implicated in the processes of either
production of secondary metabolites or morphological di¡er-
entiation. It has thus been suggested that the bldA gene may
act as a translational regulator of this type of genes [6]. The
existence of bldA mutants in Streptomyces lividans and S.
griseus [5,7] sharing similar phenotypes to those found in S.
coelicolor suggests that translational regulatory mechanisms
by bldA homologues may be a general feature of Streptomy-
ces.
The pur cluster, which determines the biosynthetic pathway
of puromycin from Streptomyces alboniger, has been cloned in
the heterologous host S. lividans, a puromycin non-producing
organism. In these transformants, puromycin biosynthesis was
regulated during growth in a similar manner to that in S.
alboniger [8]. This ¢nding suggests that either a regulatory
system is included in pur or it is present in S. lividans. How-
ever, the pur cluster, which was completely characterized (Fig.
1), lacks any apparent regulatory gene [9]. Therefore, its reg-
ulation should be dependent on common mechanisms within
S. lividans and S. alboniger. In this respect, two genes of this
cluster, pur10 and pur6 (Fig. 1) contain a TTA codon within
their amino-terminal coding regions (Leu3 for pur6 and Leu29
for pur10) [9]. This suggests that both genes, and consequently
puromycin biosynthesis, may be regulated/dependent by/on
the bldA product. Moreover, the pur10 gene product (Pur10)
appears to catalyze the ¢rst step of the pathway, which makes
it a most likely target for translational control. In the present
work, the expression of the pur cluster is studied in S. lividans
bldA and bldA39 mutant strains. The results indicate that in
this organism puromycin biosynthesis is indeed dependent on
the bldA product.
2. Materials and methods
2.1. Strains, plasmids, media and DNA methodology
The isogenic strains wild-type S. lividans 1326-9 [10] and its bldA39
mutant derivative S. lividans J1725 [5] were provided by Dr. B.K.
Leskiw (Edmonton, Canada). Escherichia coli DH5 was described
[11]. The Streptomyces-E. coli cosmid pPB5.13, a pKC505 derivative
construct [12], which carries the pur cluster [8], Streptomyces vectors
pIJ486 [13] and its bldA-containing pIJ584 plasmid [14] have been
described. Plasmid DNA from Streptomyces and E. coli was prepared
as described [15]. Streptomyces were grown in solid media R5 [15].
Puromycin production liquid medium for Streptomyces was S medium
containing starch as a carbon source [8]. Streptomyces were grown at
30‡C. Liquid and agar media for E. coli were Luria-Bertani and Lu-
ria-Bertani plus 2% agar respectively [16]. Transformation of E. coli
and Streptomyces was performed as described [15]. Streptomyces
transformants were selected on R5 plates in the presence of 25 Wg/
ml apramycin and/or 10 Wg/ml thiostrepton [12,15]. The presence of
cosmid DNA was con¢rmed by transforming E. coli DH5 with DNA
isolated from S. lividans transformants. E. coli transformants were
selected on LB plates containing 100 Wg/ml apramycin. Plasmid struc-
tures were examined by restriction endonuclease analyses of isolated
plasmid DNA.
2.2. Puromycin production
To determine production pro¢les, transformants were grown in
£asks containing 100 ml S medium, supplied with the required anti-
biotic(s), and puromycin concentration was quantitated in culture
¢ltrates by the Pac assay [8].
2.3. Enzymic activities
Pac (puromycin-N-acetyltransferase) and NapH (N-acetylpuromy-
cin-N-acetylhydrolase) activities were determined in cell-free extracts
and in cultures ¢ltrates [8,17], respectively, from samples taken at
di¡erent intervals during the growth curves of Streptomyces strains.
3. Results
3.1. Puromycin production in S. lividans bldA+ and bldA39
mutant containing pur
To study the e¡ect of bldA on puromycin production, the
bldA strain S. lividans 1326-9 and its bldA39 mutant deriva-
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tive S. lividans J1725 were transformed with the pur-contain-
ing cosmid pPB5.13. Puromycin production pro¢les were
studied during the growth curve of a representative of both
types of transformants. As Fig. 2 shows, the production of
puromycin by S. lividans 1326-9(pPB5.13) reached maximum
values (7.5 nmol per ml) and displayed a pro¢le similar to
those found previously for S. lividans 1326(pPB5.13) and S.
alboniger [8]. In contrast, the puromycin production levels by
S. lividans J1725(pPB5.13) were drastically reduced (0.18 nmol
per ml, at the highest). These results suggest that bldA a¡ects
puromycin biosynthesis in some way.
3.2. Reversion of the puromycin non-producing phenotype by
bldA
To prove that the bldA gene played a role in the expression
of pur, the S. lividans 1326-9(pPB5.13) and S. lividans
J1725(pPB5.13) strains were transformed with the bldA-con-
taining pIJ584 plasmid, which is a derivative of vector pIJ486.
Puromycin production was again determined during the
growth curves of a typical representative of both types of
transformants. Both types showed a similar pro¢le of puro-
mycin production (Fig. 2). As a control, an S. lividans
J1725(pPB5.13) transformed with the pIJ486 vector, did not
produce puromycin (data not shown). Therefore, the reversion
of the non-producing phenotype in the relevant strain was due
exclusively to bldA.
3.3. Study of the Pac and NapH activities
To gain additional information on the dependence of bldA
by pur, the Pac and NapH enzymic activities, which catalyze
speci¢c steps of the puromycin biosynthetic pathway [8,17],
were determined during the growth curves of S. lividans 1326-
9(pPB5.13) and S. lividans J1725(pPB5.13). The genes encod-
ing these enzymes lack TTA codons. Table 1 shows that in the
bldA39(pPB5.13) strain NapH and Pac activities were pro-
duced, although at a lower rate of one and two order of
magnitude, respectively, relative to the bldA(pPB3.15) strain.
This result indicates that the expression of TTA-lacking genes
of the pur cluster is also a¡ected by the bldA gene.
4. Discussion
This work has addressed aspects of the mechanisms which
a¡ect the biosynthesis of the aminonucleoside antibiotic pur-
omycin. The results clearly show that in S. lividans, a heter-
ologous host, the bldA gene plays a key role on the expression
of the pur cluster from S. alboniger. Thus, whereas a bldA
mutant strain almost does not produce puromycin, the bldA
strain is able to express pur. Moreover, the non-producing
phenotype is reverted by the bldA gene. Because the puromy-
cin production in S. lividans (pur) is regulated during growth
in a similar way to that in S. alboniger [8], it may be inferred
that in the latter organism, expression of pur is also dependent
on the bldA gene. Indeed, two genes of pur, pur6 and pur10,
contain a TTA codon at their amino-terminal ends [9], which
suggests that their coding sequences can not be translated in
the absence of a bldA wild-type gene. In addition, we have
shown that the expression in the S. lividans bldA mutant strain
of two other pur genes, napH and pac, which lack TTA co-
dons, is reduced to di¡erent extents with respect to that in the
bldA strain. This ¢nding suggests that the lack of translation
of coding sequences which carry TTA codons a¡ects expres-
sion of additional genes of pur. In fact, this result might be
expected considering that all the structural biosynthetic genes
of pur are transcribed in a single polycistronic mRNA and,
therefore, they should be regulated as a unit [9] (Fig. 1). The
napH gene is the ¢rst to be translated whereas pac is located
downstream of pur10 and pur6 [9] (Fig. 1). It is thus to be
expected that in the bldA39 strain, similarly to what happens
with antibiotics which prevent aminoacyl-tRNA binding to
the ribosomal A site (i.e. tetracyclin) [18], UUA codons at
this ribosomal site would stop translation because of a lack
of the cognate tRNALeu. Consequently, this will freeze the
ribosomes and prevent new rounds of translation as well as
the ribosomes from reaching the genes located downstream of
UUA codons. Under these conditions, some ribosomes should
detach from mRNA and translation of pur would occur at
low levels [18,19]. We would, therefore, expect a slowdown
of the rate of translation of genes (i.e. napH ; Fig. 1) which
are located upstream of genes encoding UUA codons (pur10
and pur6) and very low translation rate of genes located
downstream of these genes (i.e. pac ; Fig. 1), as it has been
found experimentally (Table 1).
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Fig. 1. Gene organization of the pur cluster. This ¢gure is modi¢ed from [9]. NapH, pac, dmpM and pur8 encode N-acetylpuromycin-N-acetyl-
hydrolase, puromycin-N-acetyltransferase, 0-demethylpuromycin-0-methyltransferase and a transmembrane protein which confers puromycin re-
sistance, respectively ([9], and references therein). pur7, pur10, pur6, pur4, pur5 and pur3 encode putative NTP pyrophosphohydrolase, oxidore-
ductase, tyrosinyltransferase, aminotransferase, methyltransferase and monophosphatase activities, respectively [9]. Size of the genes is indicated
by continuous arrows. Dotted arrows indicate the length and direction of transcription of pur transcripts [9].
Table 1
Values of Pac and NapH activities at di¡erent intervals of the
growth curves of two di¡erent Streptomyces strains
Optical densitya S. lividans 1326-
9(pPB5.13)
S. lividans
J1725(pPB5.13)
NapHb Pacc NapHb Pacc
2.0 19.2 7.5 1.3 0.06
3.0 43.3 18.1 3.2 0.09
4.5 50.3 26.6 3.8 0.19
aDetermined at 660 nm.
bDetermined as nmol of hydrolyzed N-acetylpuromycin per min per
mg of protein.
cDetermined as nmol of acetylated puromycin per min per mg of
protein.
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Fig. 2. A: Puromycin production during growth of S. lividans 1326-9 (bldA) and J1725 (bldA39) each carrying the pur cluster-containing
pPB5.13 cosmid [8]. B: As in A except that both strains were transformed with the bldA-containing pIJ584 plasmid [14]. Cells were grown on
liquid S medium at 30‡C. At the indicated intervals, the optical density at 660 nm was determined and samples of the cultures were removed
immediately to quantitate puromycin by the enzymic Pac assay from the relevant ¢ltrates.
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